Skip to content
Open access · CC-BY via OpenAlex

Age‐dependent loss of hepatic SIRT1 enhances NLRP3 inflammasome signaling and impairs capacity for liver fibrosis resolution

Jennifer Adjei‐Mosi, Qing Sun, Steven Blake Smithson, Gavyn Lee Shealy, Krupa Dhruvitha Amerineni, Zerong Liang, Hanqing Chen, Mei Wang, Qinggong Ping, Jingyan Han, Masahiro Morita, Amrita Kamat, Nicolas Musi, Mengwei Zang

Aging Cell · 2023 · ▲ 54 citations

Abstract

Our studies indicate that the longevity factor SIRT1 is implicated in metabolic disease; however, whether and how hepatocyte-specific SIRT1 signaling is involved in liver fibrosis remains undefined. We characterized a functional link of age-mediated defects in SIRT1 to the NLRP3 inflammasome during age-related liver fibrosis. In multiple experimental murine models of liver fibrosis, we compared the development of liver fibrosis in young and old mice, as well as in liver-specific SIRT1 knockout (SIRT1 LKO) mice and wild-type (WT) mice. Liver injury, fibrosis, and inflammation were assessed histologically and quantified by real-time PCR analysis. In a model of hepatotoxin-induced liver fibrosis, old mice displayed more severe and persistent liver fibrosis than young mice during liver injury and after injury cessation, as characterized by inhibition of SIRT1, induction of NLRP3, infiltration of macrophages and neutrophils, activation of hepatic stellate cells (HSCs), and excessive deposition and remodeling of the extracellular matrix. Mechanistically, deletion of SIRT1 in hepatocytes resulted in NLRP3 and IL-1β induction, pro-inflammatory response, and severe liver fibrosis in young mice, mimicking the ability of aging to impair the resolution of established fibrosis. In an aging mouse model, chronic-plus-binge alcohol feeding-induced liver fibrosis was attenuated by treatment with MCC950, a selective NLRP3 inhibitor. NLRP3 inhibition ameliorated alcoholic liver fibrosis in old mice by repressing inflammation and reducing hepatocyte-derived danger signaling-ASK1 and HMGB1. In conclusion, age-dependent SIRT1 defects lead to NLRP3 activation and inflammation, which in turn impairs the capacity to resolve fibrosis during aging.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1111/acel.13811
Canonical
link ↗
Fetched
2026-10-24 MST

Cite this

APA
Adjei‐Mosi, J., Sun, Q., Smithson, S.B., Shealy, G.L., Amerineni, K.D., Liang, Z., Chen, H., Wang, M., Ping, Q., Han, J., Morita, M., Kamat, A., Musi, N., &amp; Zang, M. (2023). Age‐dependent loss of hepatic SIRT1 enhances NLRP3 inflammasome signaling and impairs capacity for liver fibrosis resolution. <em>Aging Cell</em>. https://doi.org/10.1111/acel.13811
Vancouver
Adjei‐Mosi J, Sun Q, Smithson SB, Shealy GL, Amerineni KD, Liang Z, et al. Age‐dependent loss of hepatic SIRT1 enhances NLRP3 inflammasome signaling and impairs capacity for liver fibrosis resolution. Aging Cell. 2023. doi:10.1111/acel.13811.
BibTeX
@article{jennifer2023Agedep, title = {Age‐dependent loss of hepatic SIRT1 enhances NLRP3 inflammasome signaling and impairs capacity for liver fibrosis resolution}, author = {Jennifer Adjei‐Mosi and Qing Sun and Steven Blake Smithson and Gavyn Lee Shealy and Krupa Dhruvitha Amerineni and Zerong Liang and Hanqing Chen and Mei Wang and Qinggong Ping and Jingyan Han and Masahiro Morita and Amrita Kamat and Nicolas Musi and Mengwei Zang}, journal = {Aging Cell}, year = {2023}, doi = {10.1111/acel.13811}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings